Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Synthetic Biologics Announces Positive FDA Meeting on SYN-004 Development

americanpharmaceuticalreviewNovember 29, 2018

Tag: Synthetic Biologics , FDA , SYN-004 , CDI

PharmaSources Customer Service